Dr. Borrello is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Tampa General Cir
Fl 3
Tampa, FL 33606Phone+1 813-844-7585Fax+1 443-287-4653
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1995 - 1998
- University of ChicagoResidency, Internal Medicine, 1992 - 1995
- Virginia Commonwealth University School of MedicineClass of 1992
Certifications & Licensure
- FL State Medical License 2022 - 2025
- MD State Medical License 1995 - 2024
- IL State Medical License 1992 - 1995
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2001 Apr 01
- Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma Start of enrollment: 2005 Jun 01
- Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma Start of enrollment: 2004 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsCD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia.Francesco Mazziotta, Luca Biavati, Joseph Rimando, Sergio Rutella, Nicholas Borcherding
Blood. 2024-09-12 - Tumor-Specific CD8T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes.Elizabeth M Zawidzka, Luca Biavati, Amy Thomas, Claudio Zanettini, Luigi Marchionni
Biorxiv. 2023-08-29 - Embracing Myeloma Chimeric Antigen Receptor-T: From Scientific Design to Clinical Impact.Hitomi Hosoya, Paula Rodriguez-Otero, Surbhi Sidana, Ivan M Borrello
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023-06-01
Press Mentions
- Tampa General Hospital Opens Transplant Unit to Offer Cell Therapy TreatmentDecember 13th, 2024
- Tampa General Hospital Announces Launch of Outpatient Cellular-Immunotherapy Transplant Unit at the TGH Cancer InstituteDecember 12th, 2024
- Tampa General Hospital’s New Bone Marrow Transplant and Cell Therapies Unit Saved a Palm Beach County Patient’s LifeApril 1st, 2023
- Join now to see all
Grant Support
- The Role Of Myeloid Suppressor Cells In Tumor-Specific ToleranceNational Cancer Institute2007–2011
- Marrow Infiltrating Lymphocyte Immunotherapy In MyelomaNational Cancer Institute2008–2009
- Tumor Vaccines In Autologous Bone Marrow TransplantationNational Cancer Institute2001–2005
Other Languages
- Spanish, Italian, Portuguese
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ivan-borrello
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: